News Release

Nominations sought for AACR scientific awards and lectureships

Deadline: Friday, September 12, 2003

Grant and Award Announcement

American Association for Cancer Research

The American Association for Cancer Research (AACR), the nation's largest and oldest professional society of basic, translational, and clinical cancer research scientists, announces that nominations are now being accepting for awards that recognize outstanding achievement in cancer research. These awards, along with lectures by the winners, will be presented March 27-31, 2004, during the 95th AACR Annual Meeting in Orlando, Florida.

The nomination deadline for the following Awards and Lectureships is Friday, September 12, 2003. Details about the Awards and the nomination process are located on the AACR Website at www.aacr.org.

AACR–American Cancer Society Award for Research Excellence in Epidemiology or Prevention. The American Cancer Society co-sponsors this award to honor outstanding achievements in the fields of epidemiology, biomarkers, and prevention.

AACR–Joseph H. Burchenal Clinical Research Award. Bristol-Myers Squibb established this award to recognize outstanding achievements in clinical cancer research.

AACR–Bruce F. Cain Memorial Award. The Warner-Lambert Company (now Pfizer) established this award to recognize an individual or research team for outstanding preclinical research that has implications for the improved care of cancer patients. The award will recognize outstanding contributions in the fields of medicinal chemistry, biochemistry, or tumor biology as related to drug discovery and will encompass anticancer, antiviral, and antifungal agents.

AACR–G.H.A. Clowes Memorial Award. The Eli Lilly Company established this award to recognize outstanding recent accomplishments in basic cancer research, encompassing both laboratory research and epidemiological investigations.

AACR–Richard and Hinda Rosenthal Foundation Award. The Rosenthal Foundation established this award to recognize research that has made or gives the promise of soon making a notable contribution to improved clinical care in the field of cancer. The award is restricted to individuals who are engaged in the practice of medicine, who reside in the Americas, and who will not be more than age 50 at the time the award is given (March 2004).

AACR–DeWitt S. Goodman Memorial Lectureship. This lecture was established in honor of Dr. DeWitt S. Goodman, an international leader in the field of research in nutrition and cancer prevention. The Lectureship recognizes scientists who have made significant contributions to nutrition and cancer and cancer prevention.

AACR–Women in Cancer Research–Charlotte Friend Memorial Lectureship. AACR established this lecture to recognize an individual for meritorious contributions to cancer research and for furthering the advancement of women in science through leadership or by example.

Since 1961, when the first scientific award was presented, the AACR has honored 162 scientists and physicians, who, collectively, have made significant contributions to our understanding, diagnosis, prevention, and treatment of cancer. For information about the AACR's other Scientific Prizes and Awards – including the prestigious Landon-AACR Prizes for Basic and Translational Cancer Research and the Pezcoller Foundation-AACR International Award for Cancer Research – please visit the AACR Website at www.aacr.org.

###

Founded in 1907, the American Association for Cancer Research (AACR) is a professional society of more than 20,000 laboratory and clinical scientists engaged in cancer research in the United States and more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals (Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention). AACR's Annual Meeting attracts more than 16,000 participants who share new and significant discoveries in the cancer field, and the AACR's specialty meetings throughout the year focus on all the important areas of basic, translational and clinical cancer research.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.